Kim Sablich is VP at Jazz Pharmaceuticals plc (JAZZ). They have made 6 open-market trades across 2 companies since 2019, most recently 2023-06-05.
CIK 0001758790
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| JAZZ | SELL | 2023-03-08 | 2023-03-10 | $139.74 | $842K | +4.1% | +10.0% | -4.1% |
| JAZZ | SELL | 2022-06-06 | 2022-06-08 | $151.60 | $1.1M | -2.0% | +4.1% | -0.8% |
| JAZZ | SELL | 2021-11-11 | 2021-11-15 | $135.01 | $742K | -10.3% | -12.0% | +2.9% |
| MYOV | SELL | 2020-03-18 | 2020-03-19 | $7.37 | $6K | +0.8% | +54.3% | +126.6% |
| MYOV | SELL | 2020-01-15 | 2020-01-16 | $14.04 | $136K | -16.4% | -20.3% | -28.4% |
| MYOV | SELL | 2019-12-18 | 2019-12-19 | $16.22 | $42K | -7.6% | -12.3% | -55.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.